Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleCorrection: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial.AuthorsYamauchi, Hideko; Toi, Masakazu; Takayama, Shin; Nakamura, Seigo; Takano, Toshimi; Cui, Karen; Campbell, Christine; De Vos, Liesbet; Geyer Jr, Charles; Tutt, AndrewPublicationBreast Cancer (13406868), 2023, Vol 30, Issue 4, p606ISSN1340-6868Publication typeCorrection NoticeDOI10.1007/s12282-023-01468-z